CURE High Drug Prices Act
USA116th CongressHR-4158| House
| Updated: 8/5/2019
Chellie Pingree
Democratic Representative
Maine
Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
Administrative remediesCivil actions and liabilityHealth care costs and insuranceHealth care coverage and accessHealth programs administration and fundingInflation and pricesPrescription drugs
CURE High Drug Prices Act
USA116th CongressHR-4158| House
| Updated: 8/5/2019
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Chellie Pingree
Democratic Representative
Maine
Health Subcommittee, Energy and Commerce Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative remediesCivil actions and liabilityHealth care costs and insuranceHealth care coverage and accessHealth programs administration and fundingInflation and pricesPrescription drugs